Literature DB >> 31625770

Patient-centered management of actinic keratosis. Results of a multi-center clinical consensus analyzing non-melanoma skin cancer patient profiles and field-treatment strategies.

Wolfgang G Philipp-Dormston1, Maxime Battistella2, Lise Boussemart3,4, Alessandro Di Stefani5,6, Paolo Broganelli7, Kai-Martin Thoms8.   

Abstract

Introduction: Actinic keratosis (AK) is a chronic skin condition that can be a precursor to cutaneous squamous cell carcinoma. AK can recur and patients are likely to undergo multiple treatments. It is important that AK lesions are managed appropriately, and that patients are involved in treatment decisions. Materials and methods: The Supporting Professional Expertise in AK (SPEAK) program aims to facilitate this patient-centered care by identifying patient needs and aiding healthcare practitioners (HCPs) in selecting optimal treatment and communication strategies for different types of patients. Twenty-two dermato-oncologists with established expertise in the treatment of AK collaborated to describe commonly encountered psychosocial patient profiles, and to develop respective communication and treatment strategies. Results and conclusion: Six patient profiles were defined based on different psychosocial characteristics and were used to develop appropriate management approaches. We provide a systematic way of identifying these patient profiles in clinical practice and we outline communication strategies tailored to the primary needs of each type of patient. In addition, we provide recommendations for potential field-treatments that may be best suited for each profile. The recommendations provided here may help improve the communication and relationship between patients and HCPs, resulting in higher treatment adherence and improved patient outcomes.

Entities:  

Keywords:  Actinic keratosis; cutaneous squamous cell carcinoma; management

Year:  2019        PMID: 31625770     DOI: 10.1080/09546634.2019.1679335

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

Review 1.  A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.

Authors:  Laura Del Regno; Silvia Catapano; Alessandro Di Stefani; Simone Cappilli; Ketty Peris
Journal:  Am J Clin Dermatol       Date:  2022-02-19       Impact factor: 6.233

2.  Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.

Authors:  Jaime Piquero-Casals; Daniel Morgado-Carrasco; Yolanda Gilaberte; Rubén Del Rio; Antonio Macaya-Pascual; Corinne Granger; José Luis López-Estebaranz
Journal:  Dermatol Ther (Heidelb)       Date:  2020-07-17

3.  Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial.

Authors:  Theresa Steeb; Anja Wessely; Dagmar von Bubnoff; Thomas Dirschka; Konstantin Drexler; Conrad Falkenberg; Jessica C Hassel; Kinan Hayani; Svea Hüning; Katharina C Kähler; Sigrid Karrer; Christian Krammer; Ulrike Leiter; Diana Lill; Enklajd Marsela; Andreas Meiwes; Dorothée Nashan; Suzan Nasifoglu; Lutz Schmitz; Judith Sirokay; Alexander Thiem; Jochen Utikal; Alexander Zink; Carola Berking; Markus V Heppt
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

4.  Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness Perceptions.

Authors:  Dimitrios Sgouros; Adamantia Milia-Argyti; Dimitrios K Arvanitis; Eleni Polychronaki; Fiori Kousta; Antonios Panagiotopoulos; Sofia Theotokoglou; Anna Syrmali; Konstantinos Theodoropoulos; Alexander Stratigos; Dimitrios Rigopoulos; Alexander Katoulis
Journal:  Curr Oncol       Date:  2022-07-21       Impact factor: 3.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.